Lithocholate (LC) (10-300 mM) in physiological solution is sensed by vascular myocyte large conductance, calcium-and voltage-gated potassium (BK) channel b 1 accessory subunits, leading to channel activation and arterial dilation. However, the structural features in steroid and target that determine LC action are unknown. We tested LC and close analogs on BK channel (pore-forming cbv11b 1 subunits) activity using the product of the number of functional ion channels in the membrane patch (N) and the open channel probability (Po). LC (5b-cholanic acid-3a-ol), 5a-cholanic acid-3a-ol, and 5b-cholanic acid-3b-ol increased NPo (EC 50 ?45 mM). At maximal increase in NPo, LC increased NPo by 180%, whereas 5a-cholanic acid-3a-ol and 5b-cholanic acid-3b-ol raised NPo by 40%. Thus, the a-hydroxyl and the cis A-B ring junction are both required for robust channel potentiation. Lacking both features, 5a-cholanic acid-3b-ol and 5-cholenic acid-3b-ol were inactive. Three-dimensional structures show that only LC displays a bean shape with clear-cut convex and concave hemispheres; 5a-cholanic acid-3a-ol and 5b-cholanic acid-3b-ol partially matched LC shape, and 5a-cholanic acid-3b-ol and 5-cholenic acid-3b-ol did not. Increasing polarity in steroid rings (5b-cholanic acid-3a-sulfate) or reducing polarity in lateral chain (5b-cholanic acid 3a-ol methyl ester) rendered poorly active compounds, consistent with steroid insertion between b 1 and bilayer lipids, with the steroid-charged tail near the aqueous phase. Molecular dynamics identified two regions in b 1 transmembrane domain 2 that meet unique requirements for bonding with the LC concave hemisphere, where the steroid functional groups are located.